At its peak, the company was valued at US$6 billion. While the market initially believed in the value of 23andMe’s business model, its stock has been in decline for years, and the company owes ...

The company’s market value peaked at almost $6 billion after it went public in 2021, but 23andMe reported a 7% decline in revenue and losses of $174 million in the first nine months of its ...

At its peak, the company was valued at $6 billion. While the market initially believed in the value of 23andMe's business model, its stock has been in decline for years, and the company owes ...

MAX: So this week, 23andMe filed for Chapter 11 bankruptcy, and they’re currently looking for a buyer to take over the company. This was not a surprise. The company had been in decline for quite ...

“Any buyer of 23andMe will be required to comply ... go to “research and product consents” in account settings to decline permission for the company to use your data for research.

paving the way for 23andMe to sell it to whomever buys their assets. The bankruptcy comes after the company rejected previous acquisition offers; saw a steep decline in market value, in part due ...

Members of the House Committee on Energy and Commerce are raising concerns over data privacy weeks after the genetic testing ...

23andMe indicated the company plans to function in a normal ... and an opportunity to decline for their data to be sold or processed for advertising. “23andMe collected incredibly sensitive ...

claims 15 million customers and has seen its sales decline in recent months as the testing craze faded and the company suffered a data breach. Faced with the difficulties, 23andMe announced the ...

The company's market value peaked at almost $6 billion after it went public in 2021, but 23andMe reported a 7% decline in revenue and losses of $174 million in the first nine months of its current ...